Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,307 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03847649RecruitingPhase 2
Durvalumab for cancer after stopping immune therapy due to side effects
This Phase 2 trial tests whether durvalumab (an immunotherapy) can still help treat advanced cancer after you had to stop an earlier immune checkpoint medicine because of immune-related side effects. If you’re already on a durvalumab-based study, Substudy B also looks at continuing durvalumab (with or without tremelimumab) when it’s safe for you.
Edmonton, AlbertaAges 18 years+ - NCT03845205Recruiting
Liver transplant timing study for alcohol-related liver disease
This study compares early versus standard liver transplant timing for people whose liver illness was caused by alcohol use. It looks at treatment outcomes to see which approach helps patients do better.
Baltimore, MarylandAges 18 years+ - NCT03537794Recruiting
Brain scan study in treatment-resistant depression
This study compares brain synaptic density in people with treatment-resistant depression, people with depression that responds to treatment, and healthy controls. It uses a PET scan to measure synaptic density and aims to understand the biological differences.
Toronto, OntarioAges 25–65 - NCT03577041Recruiting
Cost study of eye injections for new macular degeneration
This study evaluates the cost-effectiveness of three anti-VEGF eye injection treatments (bevacizumab, ranibizumab, or aflibercept) for patients with newly diagnosed age-related macular degeneration affecting the center of vision. The research aims to understand which treatment option provides the best medical and financial value in France.
AmiensAges 18–70 - NCT03288948Recruiting
Binocular game therapy for lazy eye
This study tests a treatment that uses both eyes together (binocular games) to improve vision in children with “lazy eye” (amblyopia). It may help the weaker eye work better while the child practices at home and during study visits.
Dallas, TexasAges 4–10 - NCT02988128Recruiting
Medical device registry for Medtronic neurovascular products
This study follows people who receive a specific Medtronic neurovascular device to learn about safety and performance over time. It may help improve how these devices are used and monitored in real-world care.
Buenos AiresAges 18 years+ - NCT02993029Recruiting
Fluoride scan–guided treatment for painful knee arthritis
This trial studies a targeted treatment using a fluoride-related injection to help reduce pain from knee osteoarthritis. To join, you need a painful osteoarthritis knee and a specific bone-scan finding (SUV above 10) on an imaging test.
Shanghai, Shanghai MunicipalityAges 40 years+ - NCT02804074Recruiting
Treat “hidden” high blood pressure using 24-hour monitoring
This study looks at better treatment for people whose blood pressure looks okay in the clinic, but stays high during daily life or at night. It uses 24-hour blood pressure monitoring (a test that checks readings throughout the day) to guide care and see if it helps control “masked uncontrolled” hypertension.
MilanAges 35–80 - NCT02437526Enrolling by invitation
Testing an HIV treatment pause to see if cure is possible
This study looks at whether some people with HIV can keep the virus controlled even if they temporarily stop HIV medicines (an “analytic treatment interruption”). If you qualify, it may help researchers learn what it would take for an HIV cure.
Rochester, MinnesotaAges 18 years+ - NCT00920972RecruitingPhase 1/Phase 2
Bone marrow transplant prep for children with non-cancer blood disorders
This early-stage study tests a specific chemotherapy “conditioning” regimen to prepare the body for a bone marrow transplant in children with certain non-cancer blood or immune conditions. It may help the transplant work better, but it also carries risks from the chemotherapy and transplant process.
Phoenix, ArizonaAges Up to 20 years - NCT07880977Recruiting
Shenfu injection for preventing ventilator dependence
This trial tests whether a traditional Chinese medicine called Shenfu injection can help people on breathing machines get off them sooner. If you are on a ventilator, this treatment might reduce the chance of becoming dependent on it.
Yiwu, ZhejiangAges 19–75 - NCT01306019RecruitingPhase 1/Phase 2
Gene therapy for severe combined immunodeficiency in older children and adults
This trial tests a one-time gene therapy that aims to fix the genetic problem causing X-linked severe combined immunodeficiency (XSCID). It is for people aged 2 to 50 who lack a matched sibling donor and have persistent immune problems.
Bethesda, MarylandAges 2–50 - NCT07716449RecruitingPhase 3
Immunotherapy combo for stomach or esophagus cancer
This trial tests a new immunotherapy drug (QLS31905) combined with standard chemotherapy for people with advanced stomach or gastroesophageal junction cancer who have not had prior treatment. It aims to see if this new combination works better than the current standard treatment.
BeijingAges 18 years+ - NCT07344779Recruiting
Darolutamide with hormone therapy for advanced prostate cancer
This study looks at how well the drug darolutamide works when combined with hormone therapy, with or without chemotherapy, for men whose prostate cancer has spread. It aims to see how effective this treatment is in everyday medical practice, not just in a research lab.
Many LocationsAges 18 years+ - NCT07304154RecruitingPhase 1
Experimental cell therapy for autoimmune nerve and muscle diseases
This study tests a new treatment called KITE-363 for people with certain autoimmune diseases that have not improved with standard treatments. It aims to see if the therapy is safe and helpful for conditions like multiple sclerosis, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy.
Newport Beach, CaliforniaAges 18–75 - NCT06885034RecruitingPhase 1/Phase 2
Testing a new drug for advanced bowel or pancreatic cancer
This trial is testing an experimental drug (GSK5764227) either alone or with other treatments for people with advanced colon, rectal, or pancreatic cancer that cannot be removed with surgery. The goal is to see if the drug is safe and effective for these cancers.
Los Alamitos, CaliforniaAges 18 years+ - NCT07881016Recruiting
Long-term study of brain and mood in people with mental health conditions
This study follows people with conditions like schizophrenia, bipolar disorder, depression, or autism over time to learn more about these conditions and improve care. Participants will have clinical, biological, and imaging assessments, including MRI scans.
BesançonAges 15–60 - NCT04651673Recruiting
Knee brace program for adults with knee osteoarthritis pain
This trial looks at using a prescribed knee brace to help relieve knee pain and symptoms from knee osteoarthritis. You may be able to join if your knee braces are being provided through participating clinics and you can consent and complete study questionnaires.
Hässleholm, Skåne CountyAges 18–100 - NCT05948566RecruitingPhase 2
Stroke treatment study for patients up to 24 hours after symptoms
This study tests a new drug (TS23) that may help people who had a stroke and can get treatment between 4.5 and 24 hours after symptoms started. The drug aims to improve recovery by targeting the stroke effects, and the study compares the drug with a placebo to see if it works.
Birmingham, AlabamaAges 18 years+ - NCT07048509Recruiting
Exercise and blood vessel health in healthy and prehypertensive adults
This study compares how moderate and high-intensity interval training affect blood vessel function in healthy adults and those with slightly elevated blood pressure (prehypertension). It aims to see which exercise type may improve vascular health.
LjubljanaAges 18–50 - NCT07062965RecruitingPhase 3
PF-07248144 with fulvestrant for HR+ HER2- advanced breast cancer
This trial tests a new study medicine (PF-07248144) combined with fulvestrant in people with a certain type of advanced breast cancer (HR-positive, HER2-negative) that has worsened after previous treatments. It may be an option if you've already tried a CDK4/6 inhibitor and endocrine therapy.
Anchorage, AlaskaAges 18 years+ - NCT07640802Recruiting
Comparing talk therapies for irritability in children
This study compares two types of talk therapy for children who have frequent, intense irritability or temper outbursts. The goal is to see if a specific new therapy works better than a supportive, educational approach that does not include the active treatment techniques.
Bethesda, MarylandAges 8–17 - NCT06956014RecruitingPhase 3
Testing a new drug for chronic back and leg pain
This trial tests an investigational drug called VER-01 for people with long-term pain from a pinched nerve in the lower back. It aims to see if the drug safely reduces pain and improves daily life.
Mobile, AlabamaAges 18 years+ - NCT07619599RecruitingPhase 1
PET Scan to Track Lung Cancer Treatment Response
This study uses a special PET imaging scan to help doctors see how well pembrolizumab (an immunotherapy drug) is working against advanced non-small cell lung cancer. You'll receive the scan along with your regular pembrolizumab treatment and possible radiation therapy to help measure treatment response.
Duarte, CaliforniaAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,307 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.